Strategic Blueprint’s Epizyme, Inc EPZM Stock Holding History

Strategic Blueprint’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,900	Closed	-$25K	–	546
2022 Q2	$25K	Buy	+16,900	New	+$12.4K	﹤0.01%	486

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Strategic Blueprint's EPZM Position: Q3 2022 in Review

Strategic Blueprint sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 16,900 shares — an estimated $25K sold.

Strategic Blueprint first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $25K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Strategic Blueprint reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Strategic Blueprint sold 16,900 Epizyme, Inc shares in Q3 2022, an estimated $25K.
Strategic Blueprint first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Strategic Blueprint's Epizyme, Inc position peaked at $25K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Strategic Blueprint's 13F filing for Q3 2022, filed 8 Nov 2022.